1. ACIP (1992) Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use – Supplementary ACIP statement recommendations of the immunization practices advisory committee. MMRW Rec Rep Feb. 07, 1992/41 (RR-1); 1–10. Available from:
http://www.cdc.gov/mmwr/preview/mmwrhtml/00041801.htm
. Accessed on 5 Feb 2016
2. ACIP (1997) Pertussis vaccination: use of acellular pertussis vaccines among infants and young children recommendations of the Advisory Committee on Immunization Practices (ACIP) MMRW Rec and Rep March 28, 1997/46 (RR-7); 1–25. Available from:
http://www.cdc.gov/mmwr/preview/mmwrhtml/00048610.htm
. Accessed on 5 Feb 2016
3. Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N (2009) First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin. Vaccine 27:6034–6041
4. Bouchez V, Hegerle N, Strati F, Njamkepo E, Guiso N (2015) New data on vaccine antigen deficient Bordetella pertussis isolates. Vaccine 14:751–770
5. Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV, Advisory Committee on Immunization Practices (ACIP) (2006) Advisory Committee on Immunization Practices (ACIP) Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55(RR-3):1–34